Anti-CD47 antibodies have been shown to stimulate macrophage tumour cell phagocytosis as well as antigen-specific CD8+ T-cell cytotoxicity, highlighting a potential synergy with ICB [135]. The gene discussed is CD8A; the disease is neoplasm.